[Fibrosing pneumopathy caused by labetalol].
A diffuse interstitial pulmonary fibrosis occurred in a 74-year-old woman treated for ten years with labetalol for systemic hypertension. Bronchoalveolar lavage (BAL) revealed lymphocytic and neutrophilic alveolitis. The lack of another etiologic factor and the spontaneously favorable course after withdrawal of the drug support the hypothesis of a labetalol induced pulmonary fibrosis.
Kheir
A
A
Service de Médecine A, CH Remiremont.
Chabot
F
F
Delorme
N
N
Polu
J M
JM
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects*; D000368:Aged; D005260:Female; D006801:Humans; D007741:Labetalol / Q000009:adverse effects*; D011658:Pulmonary Fibrosis / Q000139:chemically induced* / Q000503:physiopathology
D000319:Adrenergic beta-Antagonists; D007741:Labetalol
Pneumopathie fibrosante induite par le labétalol.